ME/CFS and long COVID; negative outcomes for ALS drug; donanemab
Neurology Today in 518 Huhti 2024

ME/CFS and long COVID; negative outcomes for ALS drug; donanemab

Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that explores an association between myalgic encephalomyelitis/chronic fatigue and long COVID; negative phase 3 findings on AMX0035 for ALS, and the pending approval of donanemab for Alzheimer's disease.

Suosittua kategoriassa Premium

nikotellen
tuplakaak
antin-matka
jaljilla
anni-jaajo
ihan-oikeesti
dear-shirly
hei-baby-3
maanantaimysteeri
olipa-kerran-otsikko
palmujen-varjoissa
siita-on-vaikea-puhua
sita
the-harlin-show
i-dont-like-mondays
terveisia-perheesta
aikalisa
tahtitehdas
piinan-kirous-2
grekovit